| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | 0.31 | 0.08 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.08 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.065 | 0.08 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.08 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.08 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.068 | 0.08 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.067 | 0.09 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.072 | 0.09 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.09 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | -0.054 | 0.09 |